Corneal Transplantation Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Penetrating Keratoplasty, Descemet Membrane Endothelial Keratoplasty (DMEK), Descemet Stripping Endothelial Keratoplasty (DSEK), Corneal Limbal Stem Cell Transplant, and Others), Indication (Fungal Corneal Ulcer, Fuchs Dystrophy, Keratoconus, Keratitis, and Others) End User (Hospitals, Eye Clinic, and Ambulatory Surgical Centers)
Publication Month: Feb 2022 | Report Code: TIPRE00027244 | No. of Pages: 167 | Category: Medical Device | Status: Published
The corneal transplantation market is projected to reach US$ 640.79 million by 2028 from US$ 420.71 million in 2021; it is estimated to grow at a CAGR of 6.2% during 2021 to 2028.
A cornea transplant (keratoplasty) is a surgical treatment that involves removing a portion of the cornea and replacing it with corneal tissue from a donor. The transparent, dome-shaped surface of the eye is known as the cornea. It is a large aspect of the eye's ability to see clearly because it is where light enters the eye. A cornea transplant can enhance the appearance of a damaged or diseased cornea while also restoring vision and reducing pain.
Strategic Insights
The growth of the corneal transplantation market is attributed to the increasing incidence of eye diseases, and the rising geriatric population. However, the risks associated with Corneal Transplantation and shortage of donor material hampers the market growth.
Lucrative Regions in Corneal Transplantation Market
Get more information on this report :
Market Insights
Surge in Geriatric Population
The geriatric patient population is growing rapidly worldwide due to a significant rise in the subset of patients older than 80. According to the US Department of Health and Human Services, 54.1 million people were aged 65 and above in 2019 (up from 39.6 million in 2020). The population will reach 80.8 million by 2040 and 94.7 million by 2060. As the number of geriatric people increases, the demands of this group for healthcare services also continue to grow. The aging of an ocular surface and corneal tissues, and the consequent impairment of visual functions lead to severe eye diseases and a significant impact on vision. The conditions that affect these vital parts of the eye place a critical medical and socioeconomic burden on society. Thus, the increase in the population of elderlies is driving the overall growth of the corneal transplant market.
Type-Based Insights
Based on type, the global corneal transplantation market has been segmented into penetrating keratoplasty, Descemet Membrane Endothelial Keratoplasty (DMEK), Descemet Stripping Endothelial Keratoplasty (DSEK), Corneal Limbal Stem Cell Transplant, and others. The penetrating keratoplasty segment held the largest share of the market in 2021 and is anticipated to register the CAGR of 6.4% in the market during the forecast period.
Corneal Transplantation Market, by Type – 2021 and 2028
Get more information on this report :
Indication-Based Insights
Based on indication, the global corneal transplantation market is segmented into fungal corneal ulcer, Fuchs dystrophy, keratoconus, keratitis, and others. The Fuchs dystrophy segment held the largest share of the market in 2021 and is anticipated to register a CAGR of 6.8% in the market during the forecast period.
End User -Based Insights
Based on end user, the Corneal Transplantations market is segmented hospitals, eye clinics, and ambulatory surgical centers. The hospital segment held the largest share of the market in 2021 and is estimated to register the highest CAGR of 6.1% in the market during the forecast period.
Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the corneal transplantation market players focus on the partnership strategy to expand their clientele, which, in turn, permits them to maintain their brand name across the world.
Company Profiles
- CorneaGen
- Alcon Inc
- Florida Lions Eye Bank
- Corneat Vision
- Aurolab, Keramed, Inc.
- Cornea Biosciences, Inc.
- Eyemedics
- Massachusetts Eye and Ear
- Lifeline Scientific, Inc.
- San Diego Eye Bank
Frequently Asked Questions
The List of Companies - Corneal Transplantation Market
- CorneaGen
- Alcon Inc.
- Florida Lions Eye Bank
- Corneat Vision
- Aurolab
- KERAMED, INC.
- CORNEA BIOSCIENCES, INC.
- EYEMEDICS
- Massachusetts Eye and Ear
- Lifeline Scientific, Inc.
- San Diego Eye Bank
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global corneal transplantation market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global cornea transplantation market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhancing the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
-
$3000 $2700
$4550 $4095$6550 $5568$8550 $6840Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount
